Addressing the trade-off between lower drug prices and incentives for pharmaceutical innovation Rena Conti, Richard G. Frank, and Jonathan Gruber Monday, November 15, 2021
High-priced drugs in Medicare Part D: Diagnosis and prescription Richard G. Frank and Richard J. Zeckhauser Thursday, January 4, 2018
T The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity Murray L. Aitken, Ernst R. Berndt, Barry P. Bosworth, Iain M. Cockburn, Richard G. Frank, Michael Kleinrock, and Bradley T. Shapiro Tuesday, October 1, 2013
